TechFlash: Cancer drug developer cuts staff for the third time in a year

Biogen research redesign aims to increase drugs coming into portfolio

TECHFLASH April 08, 2025 TECHFLASH April 08, 2025 Biogen research redesign aims to increase drugs coming into portfolio  Biogen's research organization recently went through an overhaul that... Broad, Harvard researchers win "Oscars of Science" awards  Two Massachusetts researchers are among the recipients of the Breakthrough... Mass. court issues 'bombshell' ruling on tech founder's stock sale  A tech founder's sale of his interests in his company can be taxed as... Cancer drug developer cuts staff for the third time in a year  Relay Therapeutics said it was making cuts to "streamline (its) operations,... Vertex halts type 1 diabetes trial; Watertown manufacturer sold  This past week, a Watertown cell and gene therapy manufacturer was bought,... MIT Lincoln Lab awarded $12B Air Force contract  The contract is a renewal of a longstanding contract for the Department of... He helped nab the marathon bombers. Now he heads MassCyberCenter.  In 2013, John Petrozzelli oversaw digital investigations in the hunt for... Tariffs on medical devices could raise healthcare costs The tariffs announced by President Donald Trump on Wednesday will impact...   INNO  Claude AI goes to Northeastern Northeastern University announced that it will partner with Anthropic to... FDA layoffs, ouster of top leaders dampen biotech investment A biotech market that initially showed signs of optimism after the election... View as Webpage Unsubscribe | Manage Preferences All rights reserved. © Boston Business Journal     Email sent by Boston Business Journal 70 Franklin Street, 8th Floor Boston, MA 02110